Comparison of clofibrate and caloric restriction on kinetics of very low density lipoprotein triglycerides.
Open Access
- 1 March 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 5 (2) , 153-161
- https://doi.org/10.1161/01.atv.5.2.153
Abstract
This study of 12 patients with mild-to-moderate hypertriglyceridemia compares the mechanisms of triglyceride (TG) lowering by caloric restriction and by clofibrate. Turnover rates of very low density lipoprotein triglycerides (VLDL-TG) were determined by using 3H-glycerol as a precursor. Radioactivity-time curves of VLDL-TG were analyzed with a multicompartmental model. Hypertriglyceridemia in these patients was due mainly to overproduction of VLDL-TG. Clofibrate therapy for 1 month had a variable effect on VLDL-TG levels. A group of relatively poor responders to the drug had a mild increase in the fractional catabolic rate (FCR) of VLDL-TG, but no change in production rates. The remaining patients were relatively good responders; they had increased FCR and modest reductions in synthetic rates of VLDL-TG. However, clofibrate largely failed to correct the primary defect in this group of patients, namely, the overproduction of VLDL-TG. Almost all patients responded to 1 month of caloric restriction (1000 cal/day) with marked reductions in VLDL-TG levels. The major response to reduced caloric intake was a decrease in production of VLDL-TG, although FCR was also increased to some extent. Despite these differences in mechanisms for VLDL-TG lowering, both regimens tended to raise levels of LDL and HDL.This publication has 25 references indexed in Scilit:
- Mechanism of the hypolipemic effect of clofibrate in glucose-fed menMetabolism, 1980
- Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects.Journal of Clinical Investigation, 1979
- The Mechanism of Action of Clofibrate and Tetranicotinoylfructose (Bradilan) on the Kinetics of Plasma Free Fatty Acid and Triglyceride Transport in Type IV und Type V HypertriglyceridaemiaEuropean Journal of Clinical Investigation, 1974
- Effects of Weight Reduction on Obesity STUDIES OF LIPID AND CARBOHYDRATE METABOLISM IN NORMAL AND HYPERLIPOPROTEINEMIC SUBJECTSJournal of Clinical Investigation, 1974
- Mechanism of the Hypolipemic Effect of Clofibrate in Postabsorptive ManJournal of Clinical Investigation, 1973
- Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTIONJournal of Clinical Investigation, 1973
- Plasma Endogenous Triglyceride Transport in Hypertriglyceridaemia and Effect of a Hypolipidaemic Drug (SU‐13437)European Journal of Clinical Investigation, 1972
- Inhibition of hepatic triglyceride formation by clofibrateJournal of Clinical Investigation, 1971
- Dynamics of plasma triglyceride turnover in manMetabolism, 1965
- Carbohydrate Metabolism in Two Forms of Hyperglyceridemia *Journal of Clinical Investigation, 1964